MedTrace Logo

Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy

NCT01789983 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2024-03-20

No results posted yet for this study

Summary

The study will look at conducting a medium-intense walking program called Walk With Ease with cancer patients age 60 and above who are starting chemotherapy treatment. We will measure how many of these patients complete their participation in this program.

Conditions

Interventions

BEHAVIORAL

Walk With Ease Program

The primary activity required of study subjects is a 6-week self-directed (non-group) WWE walking program that study participants do at a place and time that is convenient for them. To start the intervention/program, we schedule a brief baseline meeting with study participants to discuss the program, provide the WWE workbook, secure printed informed consent, and complete various questionnaires. Study participants are also asked to maintain a daily walking diary that is provided to them. The WWE program includes a workbook with strengthening and stretching exercises, basic facts about arthritis and PA, and information on how to individualize the program.

OTHER

Collect Blood, GA and Other Survey Tools

* Geriatric Assessment (GA) (Version 5) * Functional Assessment of Cancer Therapy-General (FACT) * Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue36 * Outcome Expectations for Exercise (OEE) scale29 * Self-Efficacy to Manage Arthritis or Joint Pain (ASE/Arthritis Self-Efficacy) * Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM)34,35 * Visual Analog Scales (VAS) Surveys included in study are listed above. Whole Blood Sample will be collected for p16 analysis.

Sponsors & Collaborators

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Hyman Muss, MD · University of North Carolina Lineberger Comprehensive Cancer Center

  • Kirsten A Nyrop, PhD · University of North Carolina Thurston Arthritis Research Center

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-09-30
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01789983 on ClinicalTrials.gov